arrow_back Back Filing freshness 10-Q FY 2024 SEC EDGAR

Bespoke Extracts, Inc.

BSPK
Price unavailable
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
14 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
51
Health
Fair
Neutral
auto_awesome

Analytical Summary

Bespoke Extracts, Inc. shows mixed fundamentals. On the positive side, Return on Common Equity (%) remains strong. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap
Dividend Yield
Revenue Growth 42.3%
Op. Margin -89.0%
ROIC 37.6%
FCF / Share $-0.08
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close.

14-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.12M
↑ +42.3%
Net Income Profit after all expenses
$-1.04M
↑ +30.0%
Operating Margin Operating profit as % of sales
-89.0%
↑ +52.5% 2th
FCF / Share Free cash flow per share
$-0.08
↓ -107.0%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
3
Returns
96
Cash Quality
56

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 60 quarters